Integration of pre‑existing cardiovascular comorbidity into CDK4/6 inhibitor selection for breast cancer.
Saved in:
| Title: | Integration of pre‑existing cardiovascular comorbidity into CDK4/6 inhibitor selection for breast cancer. |
|---|---|
| Authors: | Park C; College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, Austin, TX 78712, USA., Kim K; College of Pharmacy, The University of Texas at Austin, Austin, TX, USA., Abifaraj NB; College of Pharmacy, The University of Texas at Austin, Austin, TX, USA., Bryant SD; College of Pharmacy, The University of Texas at Austin, Austin, TX, USA., Heo JH; College of Pharmacy, The University of Texas at Austin, Austin, TX, USA. |
| Source: | Therapeutic advances in drug safety [Ther Adv Drug Saf] 2026 Jan 23; Vol. 17, pp. 20420986251414588. Date of Electronic Publication: 2026 Jan 23 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 101549074 Publication Model: eCollection Cited Medium: Print ISSN: 2042-0986 (Print) Linking ISSN: 20420986 NLM ISO Abbreviation: Ther Adv Drug Saf Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2042-0986 |
|---|---|
| DOI: | 10.1177/20420986251414588 |
